During the last session, IN8bio Inc (NASDAQ:INAB)’s traded shares were 2.01 million, with the beta value of the company hitting 0.08. At the end of the trading day, the stock’s price was $0.21, reflecting an intraday loss of -3.95% or -$0.01. The company’s market capitalization is $16.98M, and the average intraday trading volume over the past 10 days was 0.92 million shares, and the average trade volume was 5.50 million shares over the past three months.
IN8bio Inc (INAB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. INAB has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.07.
IN8bio Inc (NASDAQ:INAB) trade information
IN8bio Inc (INAB) registered a -3.95% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.95% in intraday trading to $0.21, hitting a weekly high. The stock’s 5-day price performance is -11.40%, and it has moved by -18.07% in 30 days. Based on these gigs, the overall price performance for the year is -83.15%. The short interest in IN8bio Inc (NASDAQ:INAB) is 1.67 million shares and it means that shorts have 0.67 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -13.22%. While earnings are projected to return 63.45% in 2025, the next five years will return 23.82% per annum.
INAB Dividends
IN8bio Inc is due to release its next quarterly earnings on 2025-Mar-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
IN8bio Inc (NASDAQ:INAB)’s Major holders
IN8bio Inc insiders own 5.09% of total outstanding shares while institutional holders control 36.96%, with the float percentage being 38.94%. AIGH CAPITAL MANAGEMENT LLC is the largest shareholder of the company, while 28.0 institutions own stock in it. As of 2024-06-30, the company held over 2.13 million shares (or 4.7157% of all shares), a total value of $1.8 million in shares.
The next largest institutional holding, with 1.42 million shares, is of VANGUARD GROUP INC’s that is approximately 3.2892% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.21 million.
Also, the Mutual Funds coming in first place with the largest holdings of IN8bio Inc (INAB) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 952.49 shares. This amounts to just over 1.17 percent of the company’s overall shares, with a $0.2 million market value. The same data shows that the other fund manager holds slightly less at 471.41, or about 0.58% of the stock, which is worth about $98524.0.
